Your session is about to expire
← Back to Search
Moderate Anxiety/depression: Low Intensity Stepped care for Depression (Telehealth Trial)
Telehealth Trial Summary
This trial is testing a stepped-care approach to reducing emotional distress and improving secondary outcomes in rural, post-treatment cancer survivors.
- Depression
- Cancer
- Anxiety
- Sleep Disorder
- Recurrent Disease
- Fatigue
- Quality of Life
Telehealth Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Telehealth Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the main goals that researchers are hoping to achieve with this clinical trial?
"The key metric that will be used to determine the success of this intervention is feasibility, which will be tracked from screening to the end of the study at week 13. Additionally, changes in health status (SF-36), cancer-specific distress (IES-R), depression (PHQ-9), and anxiety (GAD-7) will be monitored longitudinally to evaluate the effectiveness of the intervention."
Are there any vacancies for participants in this experiment?
"This particular clinical trial is not currently looking for patients, as indicated on clinicaltrials.gov. The study was posted on 7/19/2018 and updated last on 9/23/2022; however, there are 2396 other trials actively recruiting across the world."
how many different hospitals or research centers are participating in this trial?
"This trial has 100 open slots for patients at locations such as Marshfield Medical Center-EC Cancer Center in Eau Claire, SIH Cancer Institute in Carterville, and Olathe Health Cancer Center in Olathe."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger